Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening

Christina M. Taylor, Yaniv Barda, Oleg G. Kisselev, Garland R. Marshall

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Modulation of interactions between activated GPCRs (G-protein coupled receptors) and the intracellular (IC) signal transducers, heterotrimeric G-proteins, is an attractive, yet essentially unexplored, paradigm for treatment of certain diseases. Regulating downstream signaling for treatment of congenital diseases due to constitutively active GPCRs, as well as tumors where GPCRs are often overexpressed, requires the development of new methodologies. Modeling, experimental data, docking, scoring, and experimental testing (MEDSET) was developed to discover inhibitors that target the IC loops of activated GPCRs. As proof-of-concept, MEDSET developed and utilized a model of the interface between photoactivated rhodopsin (R*) and transducin (Gt), its G-protein. A National Cancer Institute (NCI) compound library was screened to identify compounds that bound at the interface between R* and its G-protein. High-scoring compounds from this virtual screen were obtained and tested experimentally for their ability to stabilize R* and prevent Gt from binding to R*. Several compounds that modulate signal transduction have been identified.

Original languageEnglish
Pages (from-to)5297-5303
Number of pages7
JournalJournal of Medicinal Chemistry
Volume51
Issue number17
DOIs
StatePublished - Sep 11 2008

Fingerprint

Dive into the research topics of 'Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening'. Together they form a unique fingerprint.

Cite this